Consun Pharmaceutical Group Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Consun Pharmaceutical Group Ltd with three other companies in this sector in HONG KONG : Beijing Tong Ren Tang Chinese Medicine Company Limited (2019 sales of 1.43 billion Hong Kong Dollars [US$184.84 million] of which 75% was Healthcare products and Chinese medicine), Jacobson Pharma Corporation Ltd (1.70 billion Hong Kong Dollars [US$219.93 million] of which 74% was Generic drugs), and CGN Mining Company Ltd (2.08 billion Hong Kong Dollars [US$267.93 million] ).

Sales Analysis. During the year ended December of 2019, sales at Consun Pharmaceutical Group Ltd were HK$1.96 billion (US$253.18 million). This is a decrease of 10.1% versus 2018, when the company's sales were HK$2.18 billion. Contributing to the drop in overall sales was the 50.2% decline in Yulin Pharmaceutical, from HK$739.16 million to HK$368.27 million. . However, these declines were partially offset by the increase in sales of Consun Pharmaceutical (up 10.4% to HK$1.59 billion) .